Search clinical trials for: Encorafenib + Binimetinib
Total 130 results
-
PfizerOno Pharmaceutical Co. Ltd; Pierre Fabre LaboratoriesCompletedHealthyUnited States
-
Strata OncologyMerck Sharp & Dohme LLC; Pfizer; Gilead SciencesRecruitingCancer | Advanced Solid TumorUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Pierre Fabre MedicamentCompletedMelanoma | BRAF V600E Unresectable or Metastatic Melanoma | BRAF V600E Metastatic NSCLCChina
-
PfizerRecruitingGlioma | Melanoma | Colorectal Cancer | Brain Neoplasms | Non-Small Cell Lung Cancer | Thyroid Cancer | Malignant NeoplasmsCanada, United States
-
Inge Marie SvaneRecruiting
-
University of California, San FranciscoArray BioPharmaRecruitingMelanoma Stage IV | Melanoma Stage IIIUnited States
-
University of UtahPfizerCompletedAdvanced KRAS Positive Metastatic Colorectal CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaTerminated
-
Taiho Oncology, Inc.TerminatedNon-Small Cell Lung Cancer | KRAS Gene Mutation | Advanced or Metastatic Solid Tumors Irrespective of Gene AlterationsUnited States
-
Deciphera Pharmaceuticals LLCWithdrawnGastrointestinal Stromal Tumors
-
UNICANCERCancer Research UK; National Cancer Institute, France; Servier; Pierre Fabre Medicament and other collaboratorsNot yet recruitingBiliary Tract NeoplasmsUnited Kingdom, France, Belgium
-
Pierre Fabre Pharma GmbHiOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMetastatic Colorectal CarcinomaAustria, Germany
-
University of California, San FranciscoTakeda; Array BioPharmaTerminatedProgressive Disease | Stage IV Lung Cancer | Lung Non-Small Cell Carcinoma | ROS1 Gene Rearrangement | ALK Gene Rearrangement | Stage IIIB Lung Cancer | Stage IIIC Lung Cancer | Stage IVA Lung Cancer | Stage IVB Lung CancerUnited States
-
M.D. Anderson Cancer CenterEli Lilly and Company; BioMed Valley Discoveries, IncRecruiting
-
ConvaTec Inc.CompletedSafety and Performance of Dressing Adhesive on Healthy VolunteersUnited Kingdom
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingMetastatic Melanoma | Metastatic Cutaneous Melanoma | Acral Lentiginous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Mucosal MelanomaUnited States
-
PfizerMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. Ltd; Pierre Fabre MedicamentCompletedBRAF V600E-mutant Metastatic Colorectal CancerUnited States, Spain, Korea, Republic of, United Kingdom, Australia, Czechia, Taiwan, Belgium, France, Hungary, Canada, Japan, Russian Federation, Netherlands, Israel, Germany, Turkey, Austria, Brazil, Poland, Italy, Argentina, Chile, Denmar... and more
-
Federation Francophone de Cancerologie DigestiveMerck Sharp & Dohme LLC; Pierre Fabre LaboratoriesRecruitingColorectal Cancer | BRAF V600E Mutation PositiveFrance
-
K-Group, Beta, Inc., a wholly owned subsidiary...PfizerRecruitingMetastatic Colorectal CancerSpain, Australia, United States, Italy, Germany, Poland, Hungary
-
Children's Hospital Los AngelesDana-Farber Cancer InstituteActive, not recruitingSoft Tissue Neoplasms | Low-Grade Gliomas | Malignant Neoplasms, BrainUnited States
-
Daping Hospital and the Research Institute of Surgery...Enrolling by invitation
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Melanoma | Stage IV MelanomaUnited States
-
Curegenix Inc.Merck Sharp & Dohme LLCRecruitingSolid Tumors | GI CancerUnited States, Taiwan
-
University Health Network, TorontoRecruitingNon-small Cell CarcinomaCanada
-
Deciphera Pharmaceuticals LLCPfizerRecruitingColorectal Cancer | GISTUnited States
-
Dana-Farber Cancer InstitutePfizer; Array BioPharmaActive, not recruiting
-
Fundacion OncosurPfizer; Apices Soluciones S.L.; Pierre Fabre Ibérica, S.A.CompletedTriple Negative Breast CancerSpain
-
PfizerRecruitingGlioma | Melanoma | Thyroid Cancer | Non-Small-Cell Lung CancerUnited States, Canada, Israel
-
Massachusetts General HospitalStand Up To CancerRecruitingMetastatic Colon Cancer | Stage III Colon CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePfizer; Acrotech Biopharma Inc.RecruitingMetastatic Uveal MelanomaUnited States
-
PfizerBristol-Myers SquibbCompletedMSS | RAS-mutant Colorectal CancerUnited States, Spain, Belgium, United Kingdom, Netherlands
-
Heat BiologicsTerminatedBladder CancerUnited States
-
Massachusetts General HospitalPfizer; Array BioPharmaRecruitingNSCLC | Lung Cancer | Relapsed Cancer | Resistant Cancer | MET Amplification | Anaplastic Lymphoma Kinase Gene Translocation | ROS1 RearrangementUnited States
-
Medline IndustriesWithdrawn
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMelanoma of Unknown Primary | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Metastatic Malignant Neoplasm in Lymph NodeUnited States
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)United States
-
Abramson Cancer Center at Penn MedicinePfizerActive, not recruitingNon-Small Cell Lung Cancer | KRAS Mutation-Related TumorsUnited States
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID) | Immune Thrombocytopenic Purpura (ITP) | Kawasaki SyndromeUnited States
-
Jacobio Pharmaceuticals Co., Ltd.AbbVieRecruitingNSCLC | Solid TumorUnited States
-
Deciphera Pharmaceuticals LLCRecruitingMelanoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Pancreatic Ductal AdenocarcinomaUnited States
-
Erasca, Inc.Active, not recruitingMetastatic Colorectal Cancer | Metastatic Pancreatic Ductal AdenocarcinomaUnited States
-
Swiss Group for Clinical Cancer ResearchCompletedLung Cancer | KRAS Gene Mutation | Advanced Non-small Cell Lung CancerSwitzerland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic AdenocarcinomaUnited States
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
University of OxfordPfizer; Belfast Health and Social Care Trust; Queen's University, Belfast; Saint... and other collaboratorsCompletedColorectal Cancer | Solid TumorUnited Kingdom
-
University Health Network, TorontoNovartis PharmaceuticalsCompleted
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Copenhagen Studies on Asthma in ChildhoodActive, not recruitingAsthma | Allergy | EczemaDenmark